| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 1,139,423 | |||
| Accounts receivable, net | 63,212 | |||
| Inventory | 757,500 | |||
| Prepaid expense | 34,864 | |||
| Overpayment to related parties | 0 | |||
| Total current assets | 1,994,999 | |||
| Intangible assets | 72,101 | |||
| Total assets | 2,067,100 | |||
| Accounts payable | 10,165 | |||
| Due to related parties-Related Party | 228,298 | |||
| Accrued expenses | 6,686 | |||
| Deferred revenue | 110,991 | |||
| Total current liabilities | 356,140 | |||
| Series a convertible preferred stock, 1,000,000 designated, 140,000 shares issued and outstanding at september 30, 2025 and december 31, 2024 | 14 | |||
| Common stock 0.0001 par value, 250,000,000 shares authorized 10,979,055 shares issued and outstanding at september 30, 2025 and december 31, 2024 | 1,098 | |||
| Additional paid-in capital | 1,175,211 | |||
| Accumulated earnings (deficit) | 534,637 | |||
| Total stockholders' equity (deficit) | 1,710,960 | |||
| Total liabilities and stockholders' equity (deficit) | 2,067,100 | |||
BioScience Health Innovations, Inc. (BHICD)
BioScience Health Innovations, Inc. (BHICD)